AMANDA PHELPS: Open Payments
NPI 1104101047 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,065 in 55 payments from 26 companies in 2025. Trend: 2023 $531 · 2024 $1,461 · 2025 $1,065
Food & beverage: $1,065
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $136 |
| ABBVIE INC. | 6 | $104 |
| Vanda Pharmaceuticals Inc. | 4 | $95 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $94 |
| Otsuka America Pharmaceutical, Inc. | 4 | $75 |
| Axsome Therapeutics, Inc. | 3 | $55 |
| Amgen Inc. | 3 | $44 |
| Corcept Therapeutics | 2 | $42 |
| Biogen, Inc. | 2 | $42 |
| Janssen Biotech, Inc. | 2 | $42 |
Products named: HETLIOZ, CAPLYTA, REXULTI, Auvelity, Ozempic, OTEZLA, Korlym, ZURZUVAE.
Industry payments across IN — which companies pay providers there.
